This page contains a Flash digital edition of a book.
Product News | product news Syneron medicAl lTd


eTwo Facial rejuvenation


Application Infrared light and bi-polar radio frequency Syneron Medical Ltd., the global leader in medical aesthetic products and technology, has announced the global launch of the new eTwo device, a combination of advanced technologies for facial treatments. The eTwo is FDA cleared and CE marked for dermatological procedures requiring ablation, resurfacing and wrinkle treatment. eTwo’s unique combination of Sublime™


controlled heating and Sublative™ fractional


skin treatment allows doctors and patients to see dramatic results in skin texture and laxity


both immediately and over time, as the rejuvenation process can continue for a number weeks after the procedure. More specifically, Sublime™ uses the elōs™ combination of safe and effective levels of infrared light and bi-polar radio frequency energies to remodel the deep dermal layer of the skin by stimulating new collagen growth. At the same time, Sublative™ fractionated bi-polar radio frequency technology places heat energy in the upper layers of the dermis allowing for a significant increase in collagen and elastin production for a brighter and smoother complexion. This Sublative breakthrough technology offers a high dermal impact with low epidermal disruption. Together, these two applications are taking skin rejuvenation treatments a step further.


Contact Syneron Medical Ltd. ● www.syneron.com


TA ScienceS


TA-65MD Nutraceutical


Application Nutritional supplement


The nutritional supplement TA-65MD is a specific molecule that activates the enzyme telomerase. Telomerase activation can make human cells in a laboratory immortal. And it can make certain cells in the human body live longer and change gene expression to a younger phenotype. While this is exciting, it is not the fountain of youth. Older people taking TA-65 do not miraculously become young again. However, telomerase activation does influence a number of important effects — published studies have shown it to lengthen short telomeres, rejuvenate the immune system, increase bone density, and improve executive cognitive function.


Contact TA Sciences ● www.tasciences.com pronokAl


PronokAl Weight-loss aid


Application Physician-prescribed slimming programme


The latest statistics on obesity show that 60% of adults in the UK are classified as overweight and 26% as obese. With figures higher than they have ever been before, and with a range of weight loss methods available, the discerning doctor wants to provide a sustainable and proven nutrition plan which can easily be implemented in everyday life. PronoKal is a medically supervised diet treatment to be initiated and administered exclusively by physicians. PronoKal’s global success is contributed to the fact that it is the first medically supervised diet of its kind. The model works because of the regular relationship between doctor, patient and dietician. The constant supervision along with a tailored treatment programme and re-education on eating and lifestyle habits safely reduces the patients’ weight. PronoKal is the perfect option for doctors who have patients that don’t want surgery or have failed with all other weight-loss attempts. The normal protein- based diet implemented in the initial stage of the PronoKal method is supported by extensive proven medical research. It is tailored to each patient, as their ideal body weight will affect how much protein they


76 ❚ November/December 2011 | prime-journal.com


are prescribed per day in their diet. PronoKal consists of three stages: the ‘Active Stage’ is the protein diet stage, where a combination of PronoKal products with a wide range of flavours and textures are prescribed; ‘Dietary re-education’, during which new dietary habits are developed as a platform to maintain the target weight during the third stage and beyond; ‘Maintenance’ — the patients’ newly acquired eating habits will enable them to make healthy and enjoyable meal choices. More than 200 000 patients worldwide have been treated with the PronoKal method since its launch in Spain in 2004. PronoKal has established further operations throughout Europe, Latin America, Canada, and after launching in the UK this year, has already trained 95 doctors, and gained the recent backing of a nationwide PR campaign to help raise awareness.


Contact PronoKal ● www.pronokal.co.uk


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84